RaySearch Laboratories AB (publ) (STO:RAY.B)
Sweden · Delayed Price · Currency is SEK 173.40
+1.20 (0.70%)
Nov 10, 2026, 12:54 PM CET
RaySearch Laboratories AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,332 | 1,344 | 1,192 | 1,022 | 843.65 | 641.67 | |
Revenue Growth | 3.16% | 12.78% | 16.62% | 21.16% | 31.48% | -1.52% |
Cost of Revenue | 139.2 | 101.9 | 99.5 | 106.58 | 94.99 | 50.4 |
Gross Profit | 1,193 | 1,242 | 1,093 | 915.58 | 748.66 | 591.28 |
Selling, General & Admin | 674.1 | 650.2 | 576.2 | 558.01 | 481.14 | 422.23 |
Research & Development | 264 | 270.4 | 269.4 | 237.74 | 238.77 | 233.44 |
Other Operating Expenses | -54.6 | -7.8 | -4.6 | -2.64 | -1.56 | -0.35 |
Operating Expenses | 883.5 | 912.8 | 841 | 793.1 | 718.35 | 655.32 |
Operating Income | 309.6 | 329.6 | 251.5 | 122.48 | 30.31 | -64.04 |
Interest Expense | -12.2 | -7.8 | -9 | -9.69 | -11.48 | -6.04 |
Interest & Investment Income | 7 | 7 | 11.5 | 4.9 | 1.11 | 0.71 |
Currency Exchange Gain (Loss) | -40.9 | -40.9 | 8.9 | -7.6 | 12.44 | 10.7 |
Other Non Operating Income (Expenses) | -0.2 | -0.1 | - | -0.01 | - | - |
Pretax Income | 263.3 | 287.8 | 262.9 | 110.09 | 32.38 | -58.67 |
Income Tax Expense | 58.6 | 60 | 59.4 | 28.52 | 8.6 | -11.36 |
Net Income | 204.7 | 227.8 | 203.5 | 81.57 | 23.78 | -47.32 |
Net Income to Common | 204.7 | 227.8 | 203.5 | 81.57 | 23.78 | -47.32 |
Net Income Growth | -6.62% | 11.94% | 149.47% | 243.06% | - | - |
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Change | -0.87% | - | - | - | - | - |
EPS (Basic) | 6.02 | 6.64 | 5.94 | 2.38 | 0.69 | -1.38 |
EPS (Diluted) | 6.02 | 6.64 | 5.94 | 2.38 | 0.69 | -1.38 |
EPS Growth | -5.80% | 11.94% | 149.47% | 244.84% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 396.3 | 358.9 | 471.9 | 431.64 | 307.26 | 186.19 |
Free Cash Flow Per Share | 11.65 | 10.47 | 13.77 | 12.59 | 8.96 | 5.43 |
Dividend Per Share | 4.000 | 4.000 | 3.000 | 0.700 | - | - |
Dividend Growth | 33.33% | 33.33% | 328.57% | - | - | - |
Gross Margin | 89.55% | 92.42% | 91.65% | 89.57% | 88.74% | 92.15% |
Operating Margin | 23.24% | 24.52% | 21.10% | 11.98% | 3.59% | -9.98% |
Profit Margin | 15.36% | 16.95% | 17.07% | 7.98% | 2.82% | -7.37% |
Free Cash Flow Margin | 29.75% | 26.70% | 39.59% | 42.23% | 36.42% | 29.02% |
EBITDA | 342.7 | 359.7 | 286.1 | 214.52 | 69.74 | -33.24 |
EBITDA Margin | 25.72% | 26.76% | 24.00% | 20.99% | 8.27% | -5.18% |
D&A For EBITDA | 33.1 | 30.1 | 34.6 | 92.05 | 39.43 | 30.8 |
EBIT | 309.6 | 329.6 | 251.5 | 122.48 | 30.31 | -64.04 |
EBIT Margin | 23.24% | 24.52% | 21.10% | 11.98% | 3.59% | -9.98% |
Effective Tax Rate | 22.26% | 20.85% | 22.59% | 25.90% | 26.55% | - |